Provided by Tiger Trade Technology Pte. Ltd.

Staar Surgical

23.42
-0.2050-0.87%
Volume:10K
Turnover:231.47K
Market Cap:1.17B
PE:304.41
High:23.42
Open:23.36
Low:23.12
Close:23.62
52wk High:35.87
52wk Low:15.59
Shares:50.14M
Float Shares:26.14M
Volume Ratio:0.44
T/O Rate:0.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0769
EPS(LYR):-1.6230
ROE:1.09%
ROA:5.65%
PB:3.21
PE(LYR):-14.43

Loading ...

STAAR Surgical Q2 Net Sales Jump on China Sales Growth

Reuters
·
Aug 13

STAAR Surgical Q2 EPS USD 0.16

Reuters
·
Aug 13

STAAR Surgical Q2 Gross Margin 74.5%

THOMSON REUTERS
·
Aug 13

STAAR Surgical Company: Excluding Impact of Middle East, Rest of Emea Region Grew 12% Versus Prior Year

THOMSON REUTERS
·
Aug 13

STAAR Surgical Company: Q3 2025 Results Included Recognition of $25.9 Mln Related to a One-Time Order Placed in 2024

THOMSON REUTERS
·
Aug 13

STAAR Surgical Reports Second Quarter 2026 Results

THOMSON REUTERS
·
Aug 13

U.S. Earnings Preview: After Market Close Aug. 12

Dow Jones
·
Aug 13

STAAR Surgical Names Warren Foust CEO, Effective Aug. 4, 2026

Reuters
·
Aug 06

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Staar Surgical (STAA) and Elanco Animal Health (ELAN)

TIPRANKS
·
Aug 06

Earning Preview: Staar Surgical Q2 revenue is expected to increase by 125.63%, and institutional views are bullish

Earnings Agent
·
Aug 06

Corrected-STAAR Surgical Q2 Sales in Excess of USD 90 Million VS. Ibes Estimate USD 90.3 Million (Adds Dropped Words 'In Excess Of') (July 16)

THOMSON REUTERS
·
Aug 05

Staar Surgical appoints Warren Foust as president, CEO

TIPRANKS
·
Aug 05

STAAR Surgical Names Warren Foust CEO, Effective Aug. 4, 2026

Reuters
·
Aug 05

STAAR Surgical Schedules Q2 Earnings Call, Webcast

Reuters
·
Aug 05

Staar Surgical Price Target Maintained with a $40.00/Share by Wedbush

Dow Jones
·
Aug 04

Staar Surgical Initiated at Sell by UBS

Dow Jones
·
Jul 29

UBS Initiates STAAR Surgical at Sell With $20 Price Target

MT Newswires Live
·
Jul 28

Staar Surgical Price Target Maintained with a $40.00/share by Wedbush

Dow Jones
·
Jul 22

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 21

Did STAAR Surgical’s Surging Q2 2026 Revenue Guidance Just Shift STAAR Surgical’s (STAA) Investment Narrative?

Simply Wall St.
·
Jul 20